Skip to content
Company Analysis

Aethlon Medical, Inc. AEMD

A comprehensive view of key metrics, scores, and financial health for Aethlon Medical, Inc.

Overview of Aethlon Medical, Inc.

AEMD NCM
Healthcare Medical Devices Framework: Medical Devices & Diagnostics Micro Cap
Aethlon Medical, Inc. (AEMD), is a Micro Cap company, in the Medical Devices industry, last closed at $2.02, about 0.0% overvalued vs fair value, -88.5% 1Y return, ranked 969/1122 in sector.
Metrics ROE -245.9%
USD 2.02
6.32%
(Delayed)
• Vol 90d: 90.7%
52-Week Range
Market Cap
$4.50M
Enterprise Value
$-2.04M
Overall Score
View breakdown
Overall
Growth
Fair
Profitability
Weak
Health
Weak
Efficiency
Weak
Valuation
Weak
Growth
Fair
Profitability
Weak
Health
Weak
Efficiency
Weak
Valuation
Weak
Completeness: 82%
Confidence: 87%
Updated: Mar 8
Top Beats
No strong beats yet

Quick Facts

Website https://www.aethlonmedical.com
HQ San Diego, CA
Employees 9
Fiscal year Mar 31

Next Events

Earnings Aug 12 Estimated

Fair Value Snapshot

Insufficient data
Show more details
  • Revenue data missing or non-positive

Engine Room Money Flow™

Micro Cap

Medical Devices & Diagnostics - Where revenue goes and how value is created

Flow Steps
Total Revenue
$0
Free Cash Flow
$-7.6M
26.3%%
Money Flow Bridge
Flow Direction: Money moves from left to right
Components: Breakdown shows composition of each stage
Industry-Specific: Medical Devices & Diagnostics

Quality & Reliability Indicators

FCF Conversion
57%
Poor

Free Cash Flow / Net Income — MedTech quality hallmark. ≥100% is typical and desirable; M&A amortisation makes GAAP NI lower than true cash earnings.

Locked Metric
-
Premium

Where It Leaks

Cash Flow Health critical
Significant cash flow inefficiencies identified. Multiple high-impact leaks require attention.
2
Active Leaks
0/2
Improving
0
High Impact
2
Critical
Locked Leak
Upgrade to view details
Premium
Moat Analysis Medical Devices & Diagnostics

Competitive Advantage Assessment

Evaluating Aethlon Medical, Inc.'s durable competitive advantages across 6 defense dimensions

Overall Moat Strength
40
/100
Developing
Scores based on quantitative metrics and qualitative factors

Upgrade to unlock interactive defense details

Premium access

Unlock full defense analysis

Get key signals, strengths, and risks for every moat dimension.

Upgrade to Premium Unlock all moat defenses and evidence.

Pricing Power & Consumable Moat

Strong
100
Premium
Unlock full defense details

See key signals plus strengths and risks for this moat dimension.

Upgrade for full defense analysis Premium-only evidence and insights.
For informational purposes only. Not investment advice.

Trade-Off Ledger™

Where management spends the performance budget - Growth, Profitability, or Safety

Healthcare: MedTech (Devices & Supplies) vs Industry Peers 83% Coverage
Trade-Off Triangle Visualization A ternary plot showing AEMD's balance between Growth (33.5%), Profitability (31.7%), and Safety (34.9%). Growth 33% Safety 35% Profitability 32%

Click axes to expand details. Marker shows current allocation.

3-Year Trend Analysis Locked
Upgrade to unlock the full 3-year trend analysis and deltas.

Growth

30th percentile vs peers
30
Key Signals
EPS Growth YoY 77.9% 83p Revenue CAGR 3Y -4.1% 20p Asset Growth YoY -10.8% 29p Rev Growth YoY -1.00 1p
Strengths
  • EPS Growth YoY in top 20% of peers (77.9%, 83th percentile)
  • Gross Profit Margin in top 20% of peers (1.00, 98th percentile)
Risks
  • Rev Growth YoY in bottom 20% of peers (-1.00)

Profitability

28th percentile vs peers
29
Key Signals
Strengths
Risks
Premium
Unlock full Profitability drilldowns

See the signal-level drivers and insights behind this axis. Upgrade to reveal the full Trade-Off Ledger.

Upgrade Now

Safety

31th percentile vs peers
31
Key Signals
Strengths
Safety drilldowns are available to premium members.

Two Futures

Scenario-based fair value ranges for Aethlon Medical, Inc..

Loading valuation model...
Unable to Compute Fair Value

This company cannot be valued using standard models.

What this means: The Scenario Theatre requires financial data (revenue, cash flow, shares outstanding) to calculate fair value estimates. This data may be unavailable for:

  • Recently listed companies (IPOs, SPACs)
  • Shell companies or holding companies
  • Companies that haven't filed recent financials
  • Foreign companies with limited data coverage
X.X%
X%XX%
X.X%
-XX%XX%
XX.X%
-XX%XX%
Adjust the sliders above to explore different valuation scenarios.
Unlock Premium
Reveal the full Scenario Theatre
See live sliders, narratives, and full Bear/Base/Bull outcomes.
Upgrade Now
Bear
-
- - -
- upside
-
Base
-
- - -
- upside
-
Bull
-
- - -
- upside
-
Fair Value Range Current: $-
$- $- $-
Actions & Info
Send Feedback
Please select a category.
0/1000